BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7261227)

  • 1. [Use of buflomedil hydrochloride in ocular pathology].
    Campinchi R; Schmitt A
    Bull Soc Ophtalmol Fr; 1981; 81(4-5):413-4. PubMed ID: 7261227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
    Foray J; Baisse PE; Mont JP; Cahen C
    Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
    Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Buflomedil chlorhydrate in the treatment of retinopathies].
    Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
    Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of buflomedil in the treatment of post-traumatic cerebral edema].
    Urciuoli R; Reggio S
    Agressologie; 1988 May; 29(6):469-71. PubMed ID: 3213896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
    Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
    Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
    Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE; Damiano M
    Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E; Sunseri V
    Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of buflomedil chlorhydrate in vertiginous patients. Vertigo].
    Pianura CM; Di Lillo ML; Galati F; Massatani M; Mignano M
    Minerva Cardioangiol; 1985 Jun; 33(6):369-72. PubMed ID: 4047427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
    Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
    Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R; Klaus D
    Vasa; 1984; 13(2):171-4. PubMed ID: 6741240
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
    Fagrell B; Hermansson IL
    Fortschr Med; 1985 Jan; 103(1-2):23-7. PubMed ID: 3882535
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
    Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report.
    Sterodimas A; Vargas A; Radwanski HN; Pitanguy I
    Aesthetic Plast Surg; 2008 Mar; 32(2):383-5. PubMed ID: 18058164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.